Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer

Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer

We report unexpectedly high efficacy of temsirolimus as third-line treatment in a patient with metastatic chromophobe renal cell carcinoma. After failure of two sequentially administered tyrosine kinase inhibitors, treatment with temsirolimus resulted in a prolonged partial remission of 14 months, a...

Full description

Bibliographic Details
Main Authors: Dimitrios Zardavas, Alexander Meisel, Panagiotis Samaras, Alexander Knuth, Christoph Renner, Bernhard C. Pestalozzi, Frank Stenner-Liewen
Format: Article
Language:English
Published: Karger Publishers 2011-01-01
Series:Case Reports in Oncology
Subjects:
Temsirolimus
Chromophobe renal cell cancer
Liver metastases
Sunitinib
Sorafenib
Online Access:http://www.karger.com/Article/FullText/323804

Internet

http://www.karger.com/Article/FullText/323804

Similar Items